Literature DB >> 21360267

Patent ductus arteriosus in the preterm infant: a survey of clinical practices in French neonatal intensive care units.

Olivier Brissaud1, Julie Guichoux.   

Abstract

Patent ductus arteriosus (PDA) is one of the most common problems in the care of premature infants, especially the extremely premature. There is no real consensus regarding the diagnostic criteria or treatment of a hemodynamically significant PDA. Its diagnosis, assessment, and treatment still remain challenges. Therefore, we investigated clinical practices in French tertiary neonatology centers regarding the management of PDA to compare their similarities and differences. We sent a questionnaire by email to the PDA specialist in every French tertiary neonatal intensive care unit. It contained 27 items regarding the unit's structure, method of diagnosing PDA, and treatment choices. The completed questionnaire were returned via email and analyzed blindly. The questionnaire response rate was 87.5%, which allowed us to draw some conclusions regarding French clinical practices in the care of neonates with PDA. Although the diagnostic criteria are quite similar, the therapeutic practices are rather different across neonatal care units. We highlight the great variability in French clinical practices when it comes to treating PDA and underscore the necessity for harmonization of these practices, which could be achieved using multicenter, randomized studies to identify the advantages of one approach compared with another.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21360267     DOI: 10.1007/s00246-011-9925-8

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  33 in total

1.  Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less.

Authors:  Josh Koch; Gaynelle Hensley; Lonnie Roy; Shannon Brown; Claudio Ramaciotti; Charles R Rosenfeld
Journal:  Pediatrics       Date:  2006-04       Impact factor: 7.124

Review 2.  Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.

Authors:  S S Shah; A Ohlsson
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

3.  Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity.

Authors:  Nancy Chorne; Carol Leonard; Robert Piecuch; Ronald I Clyman
Journal:  Pediatrics       Date:  2007-06       Impact factor: 7.124

Review 4.  A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus.

Authors:  Ronald L Thomas; Graham C Parker; Bart Van Overmeire; Jacob V Aranda
Journal:  Eur J Pediatr       Date:  2004-12-10       Impact factor: 3.183

5.  A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.

Authors:  B Van Overmeire; K Smets; D Lecoutere; H Van de Broek; J Weyler; K Degroote; J P Langhendries
Journal:  N Engl J Med       Date:  2000-09-07       Impact factor: 91.245

6.  Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms.

Authors:  Nandkishor S Kabra; Barbara Schmidt; Robin S Roberts; Lex W Doyle; Luann Papile; Avroy Fanaroff
Journal:  J Pediatr       Date:  2007-03       Impact factor: 4.406

7.  Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial.

Authors:  Bart Van Overmeire; Karel Allegaert; Alexandra Casaer; Christian Debauche; Wim Decaluwé; Ann Jespers; Joost Weyler; Inge Harrewijn; Jean-Paul Langhendries
Journal:  Lancet       Date:  2004 Nov 27-Dec 3       Impact factor: 79.321

8.  Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation.

Authors:  M Kluckow; N Evans
Journal:  J Pediatr       Date:  1995-11       Impact factor: 4.406

9.  Precision and accuracy of clinical and radiological signs in premature infants at risk of patent ductus arteriosus.

Authors:  P Davis; S Turner-Gomes; K Cunningham; C Way; R Roberts; B Schmidt
Journal:  Arch Pediatr Adolesc Med       Date:  1995-10

10.  Failure of ductus arteriosus closure is associated with increased mortality in preterm infants.

Authors:  Shahab Noori; Michael McCoy; Philippe Friedlich; Brianna Bright; Venugopal Gottipati; Istvan Seri; Kris Sekar
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

View more
  5 in total

1.  Prophylactic Indomethacin Revisited.

Authors:  Jeff Reese; Elaine L Shelton; James C Slaughter; Patrick J McNamara
Journal:  J Pediatr       Date:  2017-04-07       Impact factor: 4.406

2.  Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus.

Authors:  Brian C Gulack; Matthew M Laughon; Reese H Clark; Meera N Sankar; Christoph P Hornik; P Brian Smith
Journal:  Early Hum Dev       Date:  2015-09-19       Impact factor: 2.079

3.  Survey of PDA management in very low birth weight infants across Italy.

Authors:  Benjamim Ficial; Iuri Corsini; Stefano Fiocchi; Federico Schena; Irma Capolupo; Rosa Maria Cerbo; Manuela Condò; Daniela Doni; Simona La Placa; Salvatore Porzio; Katia Rossi; Sabrina Salvadori; Marilena Savoia
Journal:  Ital J Pediatr       Date:  2020-02-14       Impact factor: 2.638

4.  Neonatologist performed echocardiography (NPE) in Italian neonatal intensive care units: a national survey.

Authors:  Iuri Corsini; Benjamim Ficial; Stefano Fiocchi; Federico Schena; Irma Capolupo; Rosa Maria Cerbo; Manuela Condò; Daniela Doni; Simona La Placa; Salvatore Porzio; Katia Rossi; Sabrina Salvadori; Marilena Savoia
Journal:  Ital J Pediatr       Date:  2019-10-22       Impact factor: 2.638

5.  Clinical and echocardiographic characteristics associated with the evolution of the ductus arteriosus in the neonate with birth weight lower than 1,500g.

Authors:  Luiza Fortunato Visconti; Samira Saady Morhy; Alice D'Agostini Deutsch; Gláucia Maria Penha Tavares; Tatiana Jardim Mussi Wilberg; Felipe de Souza Rossi
Journal:  Einstein (Sao Paulo)       Date:  2013 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.